by Vandana Singh | Mar 4, 2026 | General
Aardvark Therapeutics Inc. (NASDAQ:AARD) on Monday announced to voluntarily pause its Phase 3 HERO trial for Prader-Willi Syndrome. The update has sent the stock plunge almost 61%. The decision comes as the company is conducting a comprehensive review of safety data....
by Dylan Berman | Mar 4, 2026 | General
Ross Stores, Inc. (NASDAQ:ROST) shares are trading higher Wednesday after the company reported better-than-expected fourth-quarter financial results and issued first-quarter GAAP earnings per share guidance with its midpoint above estimates on Tuesday after the market...
by Parshwa Turakhiya | Mar 4, 2026 | General
Bridgewater Associates founder Ray Dalio pointed out why gold climbed 80% to $5,200 per ounce while Bitcoin (CRYPTO: BTC) fell 25%, argued central banks won’t buy Bitcoin due to privacy and controllability issues. The Central Bank Gold Rush Gold is the second largest...
by European Capital Insights | Mar 4, 2026 | General
European central bankers are losing their reputation for independence amid a spike in international and domestic economic uncertainty. Resignation decisions by heads of the European Central Bank (ECB) and the Banque de France have fueled accusations about the...
by Akanksha Bakshi | Mar 4, 2026 | General
GitLab Inc. (NASDAQ:GTLB) stock plunged Wednesday after weak fiscal 2027 guidance overshadowed an otherwise solid fourth-quarter earnings report. Q4 Financial Highlights On the earnings front, GitLab delivered a beat on both the top and bottom lines. The company...
by Avi Kapoor | Mar 4, 2026 | General
Okta, Inc. (NASDAQ:OKTA) will release earnings results for its fourth quarter, after the closing bell on Wednesday, March 4. Analysts expect the San Francisco, California-based company to report quarterly earnings at 85 cents per share, up from 78 cents per share in...
Recent Comments